| 郑 尧,陈 雁,张馨心,李登峰,张苗苗.影像学在肾癌靶向治疗中的临床应用价值-现状与展望[J].现代生物医学进展英文版,2020,(7):1397-1400. |
| 影像学在肾癌靶向治疗中的临床应用价值-现状与展望 |
| Clinical Application Value of Imaging in Targeted Therapy of Renal Cancer-status and Prospect |
| Received:November 06, 2019 Revised:November 28, 2019 |
| DOI：10.13241/j.cnki.pmb.2020.07.044 |
| 中文关键词: 肾癌 靶向治疗 计算机断层成像 磁共振成像 功能成像 |
| 英文关键词: Renal cancer Targeted therapy Computed tomography Magnetic resonance imaging Functional imaging |
| 基金项目:北京市科技计划项目（Z161100000221091） |
| Author Name | Affiliation | E-mail | | ZHENG Yao | Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China | zheng23500@163.com | | CHEN Yan | Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China | | | ZHANG Xin-xin | Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China | | | LI Deng-feng | Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China | | | ZHANG Miao-miao | Department of Radiology, The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, 230001, China | |
|
| Hits: 709 |
| Download times: 562 |
| 中文摘要: |
| 摘要：肾癌为最常见的肾脏恶性肿瘤，其易复发及易出现远隔转移，靶向治疗已逐渐成为肾癌治疗中不可或缺的治疗手段。由于RECIST标准评价实体瘤疗效具有明显的局限性，临床实践中常使用电子计算机断层扫描（CT）、磁共振成像（MRI）评价疗效。随着技术的不断发展，很多新颖的影像学手段如动态增强超声（DCE-US）、正电子发射断层显像（PET-CT）等可以更准确更早期地评价及预测靶向治疗的疗效。本文对肾癌靶向治疗的影像学现状及展望进行综述。 |
| 英文摘要: |
| ABSTRACT: Renal cancer is the most common renal cancer, which is easy to relapse and distant metastasis. Targeted therapy has gradually become an indispensable treatment for renal cancer. Because of the limitation of the RECIST standard in evaluating the effect of solid tumors, computed tomograhy(CT) and Magnetic Resonance Imaging(MRI) are often used in clinical practice. With the continuous development of technology, many new imaging methods, such as dynamic contrast-enhanced ultrasonography(DCE-US), positron emission tomography CT(PET-CT), can more accurately and early evaluate and predict the efficacy of targeted therapy. In this paper, the imaging status and prospect of targeted therapy for renal cancer were reviewed. |
|
View Full Text
View/Add Comment Download reader |
| Close |
|
|
|
